AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

ANGLE PLC

Director's Dealing Oct 27, 2016

7484_dirs_2016-10-27_5578dbf9-8877-4a26-bdfe-e1bb5fa1db70.html

Director's Dealing

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 5413N

Angle PLC

27 October 2016

For immediate release 27 October 2016

ANGLE plc

("ANGLE" or the "Company")

Director's share purchase  

ANGLE plc (AIM: AGL OTCQX: ANPCY), the specialist medtech company, announces that it was notified today that Andrew Newland, Chief Executive of ANGLE, has purchased 1,350,000 ordinary shares of 10p each in the Company ("Ordinary Shares"). These shares were purchased at a price of 57 pence per share in accordance with the sale and repurchase agreement (the "Agreement"), as described in the Company's announcement of 12 November 2014.

The Agreement has now terminated and Mr Newland's legal and beneficial interest in the Company reverts to the same level as it was prior to the Agreement, being 7,054,686 Ordinary Shares, now representing 9.43 per cent of the Company's issued share capital.

For further information:

ANGLE plc 01483 685830
Andrew Newland, Chief Executive

Ian Griffiths, Finance Director
Cenkos Securities

Stephen Keys (Nominated adviser)

Russell Kerr, Oliver Baxendale (Sales)
020 7397 8900
FTI Consulting

Simon Conway, Mo Noonan, Stephanie Cuthbert

Kimberley Ha (US)
020 3727 1000

001 212 850 5612

This announcement contains inside information.

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHLLFVVIFLRFIR

Talk to a Data Expert

Have a question? We'll get back to you promptly.